Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0OJ7S
|
||||
Former ID |
DIB020981
|
||||
Drug Name |
SR142948A
|
||||
Synonyms |
SR-142948A
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
Download2D MOL |
||||
Formula |
C39H51N5O6
|
||||
InChI |
InChI=1S/C39H51N5O6/c1-23(2)29-21-26(37(46)43(5)15-9-14-42(3)4)12-13-31(29)44-32(35-33(49-6)10-8-11-34(35)50-7)22-30(41-44)36(45)40-39(38(47)48)27-17-24-16-25(19-27)20-28(39)18-24/h8,10-13,21-25,27-28H,9,14-20H2,1-7H3,(H,40,45)(H,47,48)
|
||||
InChIKey |
LWULHXVBLMWCHO-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
7980656, 11056515, 14815074, 39341125, 47731315, 47805619, 50112868, 50569217, 57359486, 85222213, 85788189, 113635343, 114156133, 125762525, 128552765, 134222691, 135651074, 136351150, 137142845, 137275715, 144239952, 162023294, 162223894, 175453055, 194172319, 196376815, 225052837, 233165741, 241375876, 249617535, 252156433, 252159998
|
||||
Target and Pathway | |||||
Target(s) | Neurotensin receptor type 1 | Target Info | Antagonist | [2] | |
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Reactome | Peptide ligand-binding receptors | ||||
G alpha (q) signalling events | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Peptide GPCRs | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References | |||||
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1580). | ||||
REF 2 | Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. J Pharmacol Exp Ther. 1997 Feb;280(2):802-12. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.